State of the State for Investment Funds in COVID-19 Era – Success of Specialized Funds in Venture Capital and Private Equity
![Science Chemicals EER](/sites/default/files/styles/fullscreen_4x3_767x575_1x/public/2024-07/Science%20Chemicals%20.jpg?itok=pWrLkYz6)
Large multistage and multisector funds with brand recognition can always raise another investment vehicle.
However, given that the number of funds in venture capital and private equity have increased, funds with specialized focus, either in industry, stage, or investment thesis, are also having success in fundraising. This is due to their ability to attract a high quality deal flow and to deploy downside protection across their portfolio in times such as the COVID-19 pandemic.
Join us for a timely discussion with key industry thought leaders representing several funds as we examine the climate for investment funds' activities, their fundraising, LP relationships, and the special circumstances that may be affecting their portfolio companies, both positively and negatively.
Wednesday, October 28, 2020
10:00 a.m. - 11:30 a.m. PT | 1:00 p.m. - 2:30 p.m. ET
Moderator
- Jesse Kanach
Partner, Perkins Coie
Speakers include:
- Arman Pahlavan
Partner, Perkins Coie - Jeff Mansukhani
Southwest/West regional head of the Endowment & Foundation, Cambridge Associates - Eric Benhamou
Founder & General Partner, BGV - Patrick Dunleavy
Nanaging Director, Moelis & Company - Matthew Stepan
Associate Director, Comprehensive Financial Management